SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-063035
Filing Date
2024-05-17
Accepted
2024-05-17 17:01:37
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2414800d1_s3.htm S-3 227033
2 EXHIBIT 4.7 tm2414800d1_ex4-7.htm EX-4.7 340580
3 EXHIBIT 5.1 tm2414800d1_ex5-1.htm EX-5.1 38680
4 EXHIBIT 23.1 tm2414800d1_ex23-1.htm EX-23.1 1972
5 EX-FILING FEES tm2414800d1_ex-filingfees.htm EX-FILING FEES 47730
6 GRAPHIC tm2414800d1_s3-img01.jpg GRAPHIC 9581
7 GRAPHIC tm2414800d1_ex5-1img01.jpg GRAPHIC 3865
8 GRAPHIC tm2414800d1_ex5-1img02.jpg GRAPHIC 11677
  Complete submission text file 0001104659-24-063035.txt   692243
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279516 | Film No.: 24961107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)